Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion type Assertion NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_head.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion description "[Analysis of a recent mRNA expression profiling study in breast cancer (n = 100 cases) and an array-CGH screen in medulloblastomas (n = 102 cases), revealed downregulation in 40% and genomic loss in 11% of cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_provenance.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion evidence source_evidence_literature NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_provenance.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion SIO_000772 18058815 NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_provenance.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion wasDerivedFrom befree-20150227 NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_provenance.
- NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_assertion wasGeneratedBy ECO_0000203 NP470609.RAYgRq7B5DJeLWnkfys4XA8e16r2OaeHn65yYTiQH4zrA130_provenance.